RNA-seq analysis of the treated tumors showed that among 51 genes in 17q23, PRR11 was the only gene significantly overexpressed in resistant vs. sensitive cancers (Log2 fold change = 1.15, FDR = 0.004, p = 1.02E-05; Fig. 1b). The gene discussed is PRR11; the disease is cancer.